Objectives We have previously described the antifibrotic role of the soluble guanylate cyclase (sGC). The mode of action, however, remained elusive. In the present study, we describe a novel link ...

Ironwood Pharmaceuticals, Inc.’s IRWD share price has dipped by 10.47%, which has investors questioning if this is right time ...

New Delhi: Pharmaceutical major Dr Reddy's has got approval from the Subject Expert Committee (SEC) functional under the ...

My visit to the Neal Farinah Salon was a pivotal moment in my natural hair journey. For years, I struggled to moisturize my ...

In the realm of weight loss supplements, SVELTE Keto + ACV Gummies have emerged as a frontrunner, promising a revolutionary approach to fat burning and energy enhancement. Combining the principles of ...

Alcoholism and alcohol use disorder (AUD) are major public health and socioeconomic issues. However, a handful of ...

After a quiet few years Merck has returned to the category with soluble guanylate cyclase (sGC) stimulators Adempas (riociguat) and Verquvo (vericiguat) – partnered with Bayer – for PAH and ...

After hours: January 31 at 5:43:15 p.m. EST ...

Ironwood Pharmaceuticals (NASDAQ:IRWD – Free Report) had its price objective decreased by JMP Securities from $23.00 to $14.00 in a research note issued to investors on Thursday morning,Benzinga ...

The lateral habenula (LHb) is emerging as a crucial structure capable of conveying rewarding and aversive information. Recent evidence indicates that a rapid increase in the activity of LHb neurons ...

Leerink Partnrs lowered their Q1 2025 earnings per share (EPS) estimates for Ironwood Pharmaceuticals in a research report issued on Wednesday, January 29th. Leerink Partnrs analyst F. Khurshid now ...

Both compounds can be distinguished from typical D 2 agonists, however, because they do not cause behavioral signs associated with activation of either normosensitive or supersensitive ...